Overview Leukaemias account for approximately one third of all paediatric malignancies and cause the greatest number of cancer-related deaths in children. The long-term goal of the Leukaemia Biology Program is to improve the treatment of children with leukaemia through the development of new therapies and their preclinical testing in clinically relevant experimental models.
